Black and Hispanic vs non-Hispanic White individuals with diabetes were less likely to use continuous glucose monitoring and insulin pumps.

FDA approves updated 2026-2027 COVID-19 vaccine formulations from Pfizer/BioNTech, Moderna, and Novavax targeting the XFG variant for vulnerable populations.

There was a 10-fold increase in youth-onset type 2 diabetes from 2002 to 2023, according to a study to be presented at the annual meeting of the European Associ ...

Persistent thyrotropin receptor blocking antibody positivity predicts long-term hypothyroidism in patients with and without prior Graves disease.

Sociodemographic disadvantage and neighborhood vulnerability are linked to worse CVH trajectories during the menopause transition.

Semaglutide use before or during pregnancy may increase risk for adverse outcomes like gestational diabetes and excessive weight gain.

Only 3 of the 1357 FDA-authorized artificial intelligence (AI) medical devices have been evaluated for clinical effectiveness.

The FDA approved Genglycos (pariglasgene brecaparvovec-opnr) to reduce daily cornstarch intake in patients aged 8 years and older with glycogen storage disease type Ia.

Hormonal treatments for endometriosis may lead to reduced bone mineral density in reproductive-aged women and people assigned female at birth.

The first-of-its-kind dual continuous sensor tracks real-time glucose and background ketone trends to help prevent diabetic ketoacidosis in patients taking insulin or glucose-lowering therapy.

For patients with HR-positive, HER2-positive MBC, the combination of anastrozole, palbociclib, trastuzumab, and pertuzumab shows promise.

Better performance on standardized physical fitness tests is associated with a lower risk for all-cause mortality in older adults.